Skip to main content
. 2016 Oct 9;8(3):5474–5486. doi: 10.18632/oncotarget.12547

Table 1. Comparative analysis of characteristics among the non-MVI, low-MVI and high-MVI groups.

Variable Non-MVI
(n = 180)
Low-MVI
(n = 58)
High-MVI
(n = 57)
P
Age (years)a 54(22-81) 53(29-80) 51(24-87) 0.053
Gender
Male 140(78) 45(78) 50(88) 0.243
Female 40(22) 13(22) 7(12)
HBsAg
Positive 139(77) 50(91) 47(82) 0.280
Negative 41(23) 8(9) 10(18)
Background liver
Noncirrhosis 68(38) 15(26) 15(26) 0.115
Cirrhosis 112(62) 43(74) 42(74)
Child–Pugh grade
A 176(98) 56(97) 52(91) 0.075
B 4(2) 2(3) 5(9)
ICG-R15(%)a 5.0(0.5-31.5) 4.8(1.3-30.1) 5.8(2.3-26.3) 0.440
ALT(U/L)a 35.5(9.3-617.1) 41.3(7.5-192.0) 41.1(7.3-88.5) 0.023
TB (umol/l)a 15.5(5.6-47.7) 17.3(5.8-86.2) 16.3(8.4-42.6) 0.162
GGT(U/L)a 42.1(9.9-381.3) 52.1(15.3-683.5) 64.0(11.7-432.4) * 0.026
AKP(U/L)a 78.5(32.8-252.6) 82.7(52.0-534.6) 86.2(53.7-216.6) 0.182
Albumin (g/l)a 41.9(29.3-50.8) 41.6(30.2-52.8) 41.2(23.3-49.3) 0.385
INRa 1.0(0.9-1.7) 1.0(0.9-1.4) 1.1(1.0-1.3) 0.185
Platelets (109/l)a 138(4-327) 145(37-291) 161(21-331) 0.382
AFP (ng/ml) b 25.3(0.7-350000.0) 130(1.3-311000.0) 258.5(2.9-1050000.0) * 0.008
Tumor size(cm)a 4.4(1.0-12.0) 6.0(2.0-12.0) * 6.0(3.0-11.0) * <0.001
BCLC staging
0 20(11) 4(7) 1(2) 0.770
A 160(89) 54(93) 56(98)
Tumor differentiation
Well 42(23) 6(10) * 4(7) * 0.005
Moderate/Poor 138(77) 52(90) 53(93)
Type of resection
Anatomical 96(53) 29(50) 29(51) 0.885
Non-anatomical 84(47) 29(50) 28(49)
Operation time (min)a 210(75-510) 210(90-480) 240(110-510) * # 0.018
Blood loss (mL)a 300(50-2500) 400(50-3000) 500(50-2000) 0.062
Transfusion
Yes 28(16) 18(31) * 20(35) * 0.002
No 152(84) 40(69) 37(65)

Parenthesis indicates percentage unless indicated.a median (range) * P < 0.05 for post hoc test comparison with non-MVI # P < 0.05 for post hoc test comparison with low-MVI.

HBsAg, hepatitis B surface antigen; ICG-R15, indocyanine green retention rate at 15 minutes; ALT, alanine aminotransferase; TB, total bilirubin; GGT, gamma glutamyl transpeptidase; AKP, alkaline phosphatase; INR, International Normalized Ratio; AFP, alpha-fetoprotein; MVI, microvascular invasion.